title: COVID-19-дэ эсэргүү вакцинын зүбшөөрэлэй жагсаалта
text: National regulatory authorities have granted emergency use authorizations for thirty-four COVID-19 vaccines.
  
  Nine vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax and Convidecia. Five others are under assessment by the WHO: Sputnik V, Sinopharm WIBP, Sanofi–GSK and SCB-2019.
  
  Specific versions of six vaccines have been authorized by the European Medicines Agency (EMA): Pfizer–BioNTech, Janssen, Novavax, Moderna, Oxford–AstraZeneca, and Valneva. Specific versions of another three vaccines are under evaluation by the EMA: Sputnik V, CoronaVac, and Sanofi–GSK.
  
  Note that in some countries, vaccines may be authorized solely for travel purposes. They may not be approved for the general population. For example, the CoronaVac, Covishield, BBIBP-CorV and Covaxin vaccines are not part of Australia's national vacciation program, however, they are recognised for the purpose of travel to Australia.
  
  Overview maps
  
  Oxford–AstraZeneca 
  
  The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria and Covishield, is a viral vector vaccine produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. Finland, Denmark and Norway suspended the use of the Oxford–AstraZeneca vaccine due to a small number of reports of a rare blood clot disorder. Slovakia suspended its use after the death of a predisposed recipient. South Africa suspended its use because a small trial found only minimal protection against mild to moderate disease from the locally predominant Beta variant. Japan approved the vaccine for emergency use in May 2021, but did not plan to use them immediately because of rare cases of a blood clotting disorder reported overseas. Later, Japan started to use the vaccine for people aged 40 or over to mitigate the surge of the Delta variant in August. Finland ceased use of the vaccine as the last batch expired on 30 November 2021. Until then it was only offered for those aged 65 or more due to extremely rare coagulation disorders among younger recipients of the vaccine. After this Finland will not procure more of the vaccine. The AstraZeneca vaccine is the most widely accepted internationally, and the most popular in terms of total inoculated worldwide, over 1.3 billion. The AstraZeneca vaccine is administered in more countries than any other vaccine.
  
  Full (5)
   Australia
   Brazil
   Canada
   India
   Israel
  
  Emergency (170)
   Afghanistan
   Albania
   Algeria
   Andorra
   Angola
   Argentina
   Armenia
   Azerbaijan
   Bahrain
   Bangladesh
   Benin
   Bhutan
   Bolivia
   Bosnia and Herzegovina
   Botswana
   Brunei
   Burkina Faso
   Cambodia
   Cameroon
   Cape Verde
   Central African Republic
   Chile
   Colombia
   Comoros
   Congo-Brazzaville
   Congo-Kinshasa
   Costa Rica
   Djibouti
   Dominican Republic
   East Timor
   Ecuador
   Egypt
   El Salvador
   Eswatini
   Ethiopia
   Fiji
   Gambia
   Georgia
   Ghana
   Guatemala
   Guinea-Bissau
   Guinea
   Honduras
   Indonesia
   Iran
   Iraq
   Ivory Coast
   Japan
   Jordan
   Kenya
   Kiribati
   Kosovo
   Kuwait
   Kyrgyzstan
   Laos
   Lebanon
   Lesotho
   Liberia
   Libya
   Madagascar
   Malawi
   Malaysia
   Maldives
   Mali
   Mauritania
   Mauritius
   Mexico
   Micronesia
   Moldova
   Mongolia
   Montenegro
   Morocco
   Mozambique
   Myanmar
   Namibia
   Nauru
   Nepal
   New Zealand
   Nicaragua
   Niger
   Nigeria
   North Macedonia
   Oman
   Pakistan
   Palestine
   Panama
   Papua New Guinea
   Paraguay
   Peru
   Philippines
   Qatar
   Rwanda
   Samoa
   São Tomé and Príncipe
   Saudi Arabia
   Senegal
   Serbia
   Seychelles
   Sierra Leone
   Singapore (restricted)
   Solomon Islands
   Somalia
   South Korea
   South Sudan
   Sri Lanka
   Sudan
   Syria
   Taiwan
   Tajikistan
   Thailand
   Togo
   Tonga
   Tunisia
   Turkmenistan
   Tuvalu
   Uganda
   Ukraine
   United Arab Emirates
   United Kingdom
   Uruguay
   Uzbekistan
   Vanuatu
   Vietnam
   Yemen
   Zambia
   Zimbabwe
  
   Austria
   Belgium
   Bulgaria
   Croatia
   Cyprus
   Czech Republic
   Denmark
   Estonia
   Finland
   France
   Germany
   Greece
   Hungary
   Iceland
   Ireland
   Italy
   Latvia
   Liechtenstein
   Lithuania
   Luxembourg
   Malta
   Netherlands
   Norway
   Poland
   Portugal
   Romania
   Slovakia
   Slovenia
   Spain
   Sweden
  
   Antigua and Barbuda
   Bahamas
   Barbados
   Belize
   Dominica
   Grenada
   Guyana
   Haiti
   Jamaica
   Saint Kitts and Nevis
   Saint Lucia
   Saint Vincent and the Grenadines
   Suriname
   Trinidad and Tobago
  Non-country entities
   Anguilla
   Aruba
   British Virgin Islands
   Bermuda
   Caribbean Netherlands
   Cayman Islands
   Curaçao
   Cook Islands
   Falkland Islands
   French Polynesia
   Greenland
   Guadeloupe
   Guernsey
   Isle of Man
   Jersey
   Montserrat
   Northern Cyprus
   Pitcairn
   Saint Helena, Ascension and Tristan da Cunha
   Sint Maarten
   Turks and Caicos Islands
   Wallis and Futuna
   World Health Organization
  Travel-only
   Hong Kong
   Switzerland
   Turkey
   United States
  
  Pfizer–BioNTech 
  
  The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA vaccine produced by the German company BioNTech and the American company Pfizer. In Hong Kong, Macau, and Taiwan, Comirnaty is distributed by Fosun Pharma.
  
  Full (10)
   Australia
   Brazil
   Canada
   Marshall Islands
   Micronesia
   New Zealand
   Palau
   Saudi Arabia
   Switzerland
   United States
  
  Emergency (140)
   Afghanistan
   Albania
   Algeria
   Andorra
   Argentina
   Armenia
   Azerbaijan
   Bahrain
   Bangladesh
   Benin
   Bhutan
   Bolivia
   Bosnia and Herzegovina
   Botswana
   Brunei
   Cameroon
   Cape Verde
   Chile
   Colombia
   Congo-Kinshasa
   Costa Rica
   Djibouti
   Dominican Republic
   East Timor
   Ecuador
   Egypt
   El Salvador
   Eswatini
  Fiji
   Gabon
   Georgia
   Ghana
   Guatemala
   Guinea
   Honduras
   Indonesia
   Iraq
   Israel
   Ivory Coast
   Japan
   Jordan
   Kazakhstan
   Kenya
   Kosovo
   Kuwait
   Kyrgyzstan
   Laos
   Lebanon
   Libya
   Malawi
   Malaysia
   Maldives
   Mexico
   Moldova
   Monaco
   Mongolia
   Montenegro
   Morocco
   Namibia
   Nepal
   Nicaragua
   Nigeria
   North Macedonia
   Oman
   Pakistan
   Palestine
   Panama
   Papua New Guinea
   Paraguay
   Peru
   Philippines
   Qatar
   Rwanda
   San Marino
   Serbia
   Singapore
   South Africa
   South Korea
   Sri Lanka
   Sudan
   Taiwan
   Tajikistan
   Tanzania
   Thailand
   Tonga
   Tunisia
   Turkey
   Uganda
   Ukraine
   United Arab Emirates
   United Kingdom
   Uruguay
   Uzbekistan
   Vatican City
   Vietnam
   Zambia
  
   Austria
   Belgium
   Bulgaria
   Croatia
   Cyprus
   Czech Republic
   Denmark
   Estonia
   Finland
   France
   Germany
   Greece
   Hungary
   Iceland
   Ireland
   Italy
   Latvia
   Liechtenstein
   Lithuania
   Luxembourg
   Malta
   Netherlands
   Norway
   Poland
   Portugal
   Romania
   Slovakia
   Slovenia
   Spain
   Sweden
  
   Antigua and Barbuda
   Bahamas
   Barbados
   Belize
   Dominica
   Grenada
   Guyana
   Haiti
   Jamaica
   Saint Kitts and Nevis
   Saint Lucia
   Saint Vincent and the Grenadines
   Suriname
   Trinidad and Tobago
  
  Non-country entities
   American Samoa
   Anguilla
   Aruba
   Bermuda
   British Virgin Islands
   Caribbean Netherlands
   Cayman Islands
   Cook Islands
   Curaçao
   Faroe Islands
   French Polynesia
   Gibraltar
   Greenland
   Guadeloupe
   Guam
   Guernsey
   Hong Kong
   Isle of Man
   Jersey
   Macau
   Martinique
   Montserrat
   New Caledonia
   Niue
   Northern Cyprus
   Northern Mariana Islands
   Puerto Rico
   Sint Maarten
   Tokelau
   Turks and Caicos Islands
   World Health Organization
  
  Janssen 
  
  The Janssen COVID-19 vaccine is a viral vector vaccine produced by Janssen Pharmaceutica (a subsidiary of Johnson & Johnson) and Beth Israel Deaconess Medical Center. It is also known as Johnson & Johnson COVID-19 Vaccine and as COVID-19 Vaccine Janssen. Three countries, Denmark, Finland, and Norway, discontinued the use of the Janssen vaccine in favor of other available vaccines due to a possible link between the vaccine and a rare blood clot disorder. The use of the Janssen adenovirus vector vaccine began in Finland in October 2021. It is only offered for those aged 65 and over because of a very rare risk of thrombosis in younger age groups.
  
  Full (3)
   Australia (not used)
   Canada
   Switzerland
  
  Emergency (126)
   Afghanistan
   Andorra
   Argentina
   Bahamas
   Bahrain
   Bangladesh
   Benin
   Bolivia
   Botswana
   Brazil
   Brunei
   Burkina Faso
   Cambodia
   Cameroon
   Central African Republic
   Chile
   Colombia
   Congo-Kinshasa
   Djibouti
   Egypt
   Eswatini
   Ethiopia
   Gabon
   Ghana
   Guinea
   Honduras
   India
   Indonesia
   Iran
   Ivory Coast
   Jordan
   Kenya
   Kuwait
   Laos
   Lesotho
   Liberia
   Libya
   Madagascar
   Malawi
   Malaysia
   Maldives
   Mali
   Marshall Islands
   Mauritania
   Mexico
   Micronesia
   Moldova
   Morocco
   Mozambique
   Namibia
   Nepal
   New Zealand
   Nicaragua
   Nigeria
   Palau
   Palestine
   Papua New Guinea
   Peru
   Philippines
   Qatar
   Rwanda
   Saudi Arabia
   Senegal
   Singapore (restricted)
   Somalia
   South Africa
   South Korea
   South Sudan
   Sudan
   Syria
   Taiwan (not used)
   Tanzania
   Thailand
   Tunisia
   Uganda
   Ukraine
   United Kingdom
   United States
   Vietnam
   Yemen
   Zambia
   Zimbabwe
  
   Austria
   Belgium
   Bulgaria
   Croatia
   Cyprus
   Czech Republic
   Denmark
   Estonia
   Finland
   France
   Germany
   Greece
   Hungary
   Iceland
   Ireland
   Italy
   Latvia
   Liechtenstein
   Lithuania
   Luxembourg
   Malta
   Netherlands
   Norway
   Poland
   Portugal
   Romania
   Slovakia
   Slovenia
   Spain
   Sweden
  
   Antigua and Barbuda
   Bahamas
   Barbados
   Belize
   Dominica
   Grenada
   Guyana
   Haiti
   Jamaica
   Saint Kitts and Nevis
   Saint Lucia
   Saint Vincent and the Grenadines
   Suriname
   Trinidad and Tobago
  
  Non-country entities
   American Samoa
   Anguilla
   Aruba
   Bermuda
   British Virgin Islands
   Caribbean Netherlands
   Cayman Islands
   Curaçao
   French Polynesia
   Greenland
   Guam
   Montserrat
   New Caledonia
   Northern Cyprus
   Northern Mariana Islands
   Puerto Rico
   Sint Maarten
   Turks and Caicos Islands
   Africa Regulatory Taskforce
   World Health Organization
  Travel-only
   Hong Kong
   Turkey
  
  Moderna 
  
  The Moderna COVID-19 vaccine, also known as Spikevax, is an mRNA vaccine produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations. The Moderna vaccine is not offered for men under 30 years of age in Finland as a precaution to reduce a very rare risk of myocarditis.
  
  Full (5)
   Australia
   Canada
   Switzerland
   United Kingdom
   United States
  
  Emergency (104)
   Andorra
   Argentina
   Armenia
   Bahrain
   Bangladesh
   Bhutan
   Botswana
   Bolivia
   Brazil
   Brunei
   Cape Verde
   Chile
   Colombia
   Congo-Brazzaville
   Congo-Kinshasa
   Egypt
   El Salvador
   Fiji
   Ghana
   Guatemala
   Honduras
   India
   Indonesia
   Israel
   Japan
   Jordan
   Kenya
   Kuwait
   Kyrgyzstan
   Libya
   Malawi
   Malaysia
   Maldives
   Marshall Islands
   Mexico
   Micronesia
   Moldova
   Mongolia
   Nepal
   Nigeria
   Pakistan
   Palau
   Palestine
   Paraguay
   Peru
   Philippines
   Qatar
   Rwanda
   Saudi Arabia
   Serbia
   Singapore
   South Korea
   Sri Lanka
   Taiwan
   Tajikistan
   Thailand
   Tunisia
   Uganda
   Ukraine
   United Arab Emirates
   Uzbekistan
   Vietnam
  
   Austria
   Belgium
   Bulgaria
   Croatia
   Cyprus
   Czech Republic
   Denmark
   Estonia
   Finland
   France
   Germany
   Greece
   Hungary
   Iceland
   Ireland
   Italy
   Latvia
   Liechtenstein
   Lithuania
   Luxembourg
   Malta
   Netherlands
   Norway
   Poland
   Portugal
   Romania
   Slovakia
   Slovenia
   Spain
   Sweden
  
   Antigua and Barbuda
   Bahamas
   Barbados
   Belize
   Dominica
   Grenada
   Guyana
   Haiti
   Jamaica
   Saint Kitts and Nevis
   Saint Lucia
   Saint Vincent and the Grenadines
   Suriname
   Trinidad and Tobago
  
  Non-country entities
   American Samoa
   Anguilla
   Aruba
   Bermuda
   British Virgin Islands
   Caribbean Netherlands
   Cayman Islands
   Curaçao
   Faroe Islands
   Greenland
   Guadeloupe
   Guam
   Guernsey
   Isle of Man
   Jersey
   Montserrat
   Northern Mariana Islands
   Puerto Rico
   Sint Maarten
   Turks and Caicos Islands
   Wallis and Futuna
   World Health Organization
  Travel-only
   Hong Kong
   New Zealand
   Turkey
  
  Sinopharm BIBP 
  
  The Sinopharm BIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Beijing Institute of Biological Products.
  
  Full (4)
   Bahrain
   China
   Seychelles
   United Arab Emirates
  
  Emergency (106)
   Afghanistan
   Algeria
   Angola
   Argentina
   Armenia
   Bangladesh
   Belarus
   Bhutan
   Bolivia
   Bosnia and Herzegovina
   Brazil
   Brunei
   Burkina Faso
   Burundi
   Cambodia
   Cameroon
   Cape Verde
   Chad
   Comoros
   Congo-Brazzaville
   Cuba
   Djibouti
   Dominican Republic
   Egypt
   El Salvador
   Equatorial Guinea
   Ethiopia
   Gabon
   Gambia
   Georgia
   Guinea-Bissau
   Guinea
   Hungary
   Indonesia
   Iran
   Iraq
   Ivory Coast
   Jordan
   Kazakhstan
   Kenya
   Kiribati
   Kyrgyzstan
   Laos
   Lebanon
   Lesotho
   Libya
   Madagascar
   Malawi
   Malaysia
   Maldives
   Mauritania
   Mauritius
   Mexico
   Moldova
   Mongolia
   Montenegro
   Morocco
   Mozambique
   Myanmar
   Namibia
   Nepal
   Nicaragua
   Niger
   Nigeria
   North Korea
   North Macedonia
   Pakistan
   Palestine
   Papua New Guinea
   Paraguay
   Peru
   Philippines
   Rwanda
   Senegal
   Serbia
   Sierra Leone
   Singapore
   Solomon Islands
   Somalia
   South Sudan
   Sri Lanka
   Sudan
   Syria
   Tanzania
   Thailand
   Tunisia
   Turkmenistan
   Vanuatu
   Venezuela
   Vietnam
   Zambia
   Zimbabwe
  
   Antigua and Barbuda
   Bahamas
   Barbados
   Belize
   Dominica
   Grenada
   Guyana
   Haiti
   Jamaica
   Saint Kitts and Nevis
   Saint Lucia
   Saint Vincent and the Grenadines
   Suriname
   Trinidad and Tobago
  Non-country entities
   Anguilla
   Aruba
   British Virgin Islands
   Bermuda
   Caribbean Netherlands
   Cayman Islands
   Curaçao
   Macau
   Montserrat
   Sint Maarten
   Turks and Caicos Islands
   World Health Organization
  
  Travel-only
  
   Andorra
   Australia
   Austria (only for entry)
   Bulgaria
   Canada
   Chile
   Costa Rica
   Croatia
   Cyprus
   Czech Republic (only for Hungarian citizens and EU nationals vaccinated in Hungary)
   Estonia (only if approved in a person's country of origin)
   Finland
   Greece
   Grenada
   Hong Kong
   Iceland
   Ireland
   Latvia
   Liechtenstein
   New Zealand
   Oman
   Panama
   Portugal (only in Madeira)
   Qatar
   Saudi Arabia (for short visits, Hajj and Umrah only)
   Slovakia
   Slovenia
   South Korea
   Spain
   St. Kitts and Nevis
   St. Lucia
   St. Vincent and the Grenadines
   Sweden
   Switzerland
   The Netherlands
   Turkey
   Ukraine
   United Kingdom
   United States
   Uruguay (only if approved in a person's country of origin)
  
  Sputnik V 
  
  The Sputnik V COVID-19 vaccine is a viral vector vaccine produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology.
  Full (3)
   Russia
   Turkmenistan
   Uzbekistan
  
  Emergency (76)
   Albania
   Algeria
   Angola
   Antigua and Barbuda
   Argentina
   Armenia
   Azerbaijan
   Bahrain
   Bangladesh
   Belarus
   Bolivia
   Bosnia and Herzegovina
   Brazil (restricted)
   Cambodia
   Cameroon
   Chile
   Congo-Brazzaville
   Djibouti
   Ecuador
   Egypt
   Gabon
   Gambia
   Ghana
   Guatemala
   Guinea
   Guyana
   Honduras
   Hungary
   India
   Indonesia
   Iran
   Iraq
   Ivory Coast
   Jordan
   Kazakhstan
   Kenya
   Kyrgyzstan
   Laos
   Lebanon
   Libya
   Maldives
   Mali
   Mauritius
   Mexico
   Moldova
   Mongolia
   Montenegro
   Morocco
   Myanmar
   Namibia
   Nepal
   Nicaragua
   Nigeria
   North Macedonia
   Oman
   Pakistan
   Palestine
   Panama
   Paraguay
   Peru
   Philippines
   Rwanda
   Saint Vincent and the Grenadines
   San Marino
   Serbia
   Seychelles
   Sri Lanka
   Syria
   Tajikistan
  Tanzania
   Tunisia
   Turkey (limited use)
   United Arab Emirates
   Venezuela
   Vietnam
   Zimbabwe
  Non-country entities
   Abkhazia
   South Ossetia
  
  Expired
   Slovakia
  Rejected
   South Africa
  Travel-only
   Australia
   Cyprus
   Estonia
   Greece
   Hong Kong
   Israel
   Malaysia
   New Zealand
   Saudi Arabia
   Slovenia
   St. Lucia
   Thailand
  
  CoronaVac 
  
  The CoronaVac COVID-19 vaccine is an inactivated virus vaccine produced by the Chinese company Sinovac Biotech.
  Full (1)
   China
  
  Emergency (71)
   Albania
   Algeria
   Argentina
   Armenia
   Azerbaijan
   Bangladesh
   Benin
   Bolivia
   Bosnia and Herzegovina
   Botswana
   Brazil
   Cambodia
   Chile
   Colombia
   Djibouti
   Dominica
   Dominican Republic
   East Timor
   Ecuador
   Egypt
   El Salvador
   Equatorial Guinea
   Fiji
   Gabon
   Georgia
   Guinea
   Guyana
   Hungary
   Indonesia
   Kazakhstan
   Laos
   Libya
   Malawi
   Malaysia
   Maldives
   Mexico
   Moldova
   Morocco
   Myanmar
   Nepal
   North Macedonia
   Oman
   Pakistan
   Palestine
   Panama
   Paraguay
   Philippines
   Rwanda
   Saint Vincent and the Grenadines
   Saudi Arabia
   Singapore
   Somalia
   South Africa
   Sri Lanka
   Sudan
   Syria
   Tajikistan
   Tanzania
   Thailand
   Togo
   Trinidad and Tobago
   Tunisia
   Turkey
   Turkmenistan
   Uganda
   Ukraine
   Uruguay
   Uzbekistan
   Venezuela
   Yemen
   Zimbabwe
  
  Non-country entities
   Hong Kong
   Northern Cyprus
   World Health Organization
  
  Travel-only
  
   Andorra
   Australia
   Austria (only for entry)
   Canada
   Costa Rica
   Croatia
   Cyprus
   Estonia (only if approved in a person's country of origin)
   Finland
   Greece
   Grenada
   Iceland
   Ireland
   Liechtenstein
   Norway
   New Zealand
   Norway
   Palau
   Panama
   Portugal (only in Madeira)
   Slovakia
   Slovenia
   South Korea
   Spain
   St. Kitts and Nevis
   St. Lucia
   St. Vincent and the Grenadines
   Sweden
   Switzerland
   The Netherlands
   Ukraine
   United Arab Emirates
   United Kingdom
   United States
   Vietnam
  
  Novavax 
  
  The Novavax COVID-19 vaccine, codenamed NVX-CoV2373, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations, that is undergoing trials in India under the brand name Covovax. It requires two doses and is stable at 2 to 8 °C (36 to 46 °F) refrigerated temperatures.
  
  NVX-CoV2373 has been described as both a protein subunit vaccine and a virus-like particle vaccine, though the producers call it a "recombinant nanoparticle vaccine".
  
  Full (4)
   Australia
   Canada
   Japan
   South Korea
  
  Emergency (40)
   Bangladesh
   India
   Indonesia
   New Zealand
   Philippines
   Singapore
   Switzerland
   Thailand
   Taiwan
   United Kingdom
  
   Austria
   Belgium
   Bulgaria
   Croatia
   Cyprus
   Czech Republic
   Denmark
   Estonia
   Finland
   France
   Germany
   Greece
   Hungary
   Iceland
   Ireland
   Italy
   Latvia
   Liechtenstein
   Lithuania
   Luxembourg
   Malta
   Netherlands
   Norway
   Poland
   Portugal
   Romania
   Slovakia
   Slovenia
   Spain
   Sweden
  
  Non-country entities
   World Health Organization
  
  Travel-only
   Hong Kong
   Palau
   Panama
   St. Kitts and Nevis
   St. Lucia
   St. Vincent and the Grenadines
   Switzerland
   Turkey
   United Arab Emirates
   United States
  
  VLA2001 
  VLA2001 is an inactivated vaccine developed by Valneva SE and Dynavax Technologies.
  
  Full (31)
   United Kingdom
  
   Austria
   Belgium
   Bulgaria
   Croatia
   Cyprus
   Czech Republic
   Denmark
   Estonia
   Finland
   France
   Germany
   Greece
   Hungary
   Iceland
   Ireland
   Italy
   Latvia
   Liechtenstein
   Lithuania
   Luxembourg
   Malta
   Netherlands
   Norway
   Poland
   Portugal
   Romania
   Slovakia
   Slovenia
   Spain
   Sweden
  Emergency (2)
   Bahrain
   United Arab Emirates
  
  Travel-only
   Malaysia
   New Zealand
   Turkey
  
  Sputnik Light 
  
  Sputnik Light is a viral vector vaccine, produced by the Russian Gamaleya Research Institute of Epidemiology and Microbiology. It consists of the first dose of the Sputnik V vaccine, which is based on the Ad26 vector.
  
  Full (0)
  
  Emergency (28)
   Angola
   Argentina
   Armenia
   Bahrain
   Belarus
   Benin
   Cambodia
   Congo-Brazzaville
   Egypt
   Iran
   India
   Kazakhstan
   Kyrgyzstan
   Laos
   Mauritius
   Mongolia
   Nicaragua
   Palestine
   Philippines
   Russia
   Saint Vincent and the Grenadines
   San Marino
   Syria
   Tanzania
   Tunisia
   TurkmenistanТуркменистан зарегистрировал облегченный вариант российской вакцины «Спутник V»
   United Arab Emirates
   Venezuela
  Non-country entities
   Abkhazia
   Donbass Region (unofficially)
  
  Travel-only
   Malaysia
   New Zealand
   Turkey
  
  Covaxin 
  
  Covaxin is an inactivated virus vaccine produced by the Indian company Bharat Biotech in collaboration with the Indian Council of Medical Research–National Institute of Virology.
  
  Full (1)
   India
  Emergency (19)
   Bahrain
   Botswana
   Central African Republic
   Comoros
   Ethiopia
   Guatemala (not used)
   Guyana (not used)
   Iran
   Malaysia
   Mauritius
   Mexico (not used)
   Myanmar
   Nepal
   Nicaragua (not used)
   Paraguay
   Philippines
   Trinidad and Tobago
   Venezuela (not used)
   Vietnam
   Zimbabwe
  
  Non-country entities
   World Health Organization
  Travel-only
  
   Andorra
   Australia
   Austria (only for entry)
   Canada
   Costa Rica
   Croatia
   Cyprus
   Estonia (only if approved in a person's country of origin)
   Finland
   Greece
   Grenada
   Hong Kong
   Iceland
   Ireland
   Kyrgyzstan
   Liechtenstein
   Mongolia
   New Zealand
   Norway
   Oman
   Palestine
   Palau
   Panama
   Portugal (only in Madeira)
   Saudi Arabia
   Singapore
   Slovakia
   Slovenia
   South Korea
   Spain
   Sri Lanka
   St. Kitts and Nevis
   St. Lucia
   St. Vincent and the Grenadines
   Sweden
   Switzerland
   Thailand
   The Netherlands
   Turkey
   Ukraine
   United Kingdom
   United States
  
  Convidecia 
  
  Convidecia is a viral vector vaccine produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.
  
  Full (1)
   China
  
  Emergency (9)
   Argentina
   Chile
   Ecuador
   Hungary
   Indonesia
   Malaysia
   Mexico
   Moldova
   Pakistan
  Non-country entities
   World Health Organization
  Travel-only
   Hong Kong
   New Zealand
   Turkey
  
  Sinopharm WIBP 
  
  The Sinopharm WIBP COVID-19 vaccine is an inactivated virus vaccine produced by the China National Pharmaceutical Group (Sinopharm) and its Wuhan Institute of Biological Products.
  
  Full (1)
   China
  
  Emergency (5)
   North Macedonia
   Peru
   Philippines
   United Arab Emirates
   Venezuela
  
  Travel-only
   Hong Kong
   Malaysia
   New Zealand
   Turkey
  
  Abdala 
  
  Abdala is a subunit vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba.
  
  Full (0)
  
  Emergency (6)
   Cuba
   Mexico
   Nicaragua
   St. Vincent and the Grenadines
   Venezuela
   Vietnam
  
  Travel-only
   Cambodia
   Colombia
   Guyana
   Malaysia
   New Zealand
   St. Lucia
   Turkey
   Uruguay (only if accepted in the country of the person's origin)
  
  EpiVacCorona 
  
  EpiVacCorona is a peptide vaccine produced by the Russian State Research Center of Virology and Biotechnology VECTOR.
  
  Full (1)
   Turkmenistan
  
  Emergency (4)
   Belarus
   Cambodia
   Russia
   Venezuela
  
  Travel-only
   Malaysia
   New Zealand
   Turkey
  
  Zifivax 
  
  Zifivax is a subunit vaccine produced by the Chinese company Anhui Zhifei Longcom Biopharmaceutical.
  
  Full (0)
  
  Emergency (5)
   China
   Colombia
   Indonesia
   Pakistan
   Uzbekistan
  
  Travel-only
   Hong Kong
   Malaysia
   New Zealand
   Turkey
  
  Soberana 02 
  
  Soberana 02, is a conjugate vaccine developed by the Finlay Institute in Cuba.
  
  Full (0)
  
  Emergency (4)
   Cuba
   Iran
   Nicaragua
   Venezuela
  
  Travel-only
   Guyana
   Hungary
   Malaysia
   New Zealand
   Turkey
  
  CoviVac 
  
  CoviVac is an inactivated virus vaccine produced by the Chumakov Centre at the Russian Academy of Sciences.
  
  Full (0)
  
  Emergency (3)
   Belarus
   Cambodia
   Russia
   Travel-only
   Malaysia
   New Zealand
   Turkey
  
  QazCovid-in 
  
  QazCovid-in, also known as QazVac, is an inactivated virus vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan.
  Full (0)
  
  Emergency (2)
   Kazakhstan
   Kyrgyzstan
  
  Travel-only
   Malaysia
   New Zealand
   Turkey
  
  Minhai 
  
  Minhai COVID-19 vaccine, is an inactivated virus vaccine developed by Minhai Biotechnology Co. and Shenzhen Kangtai Biological Products Co. Ltd. in China.
  Full (0)
  
  Emergency (2)
   China
   Indonesia
  
  Travel-only
   Hong Kong
   Malaysia
   New Zealand
   Turkey
  
  Medigen 
  
  MVC-COV1901, is a protein subunit vaccine developed by Taiwan's Medigen Vaccine Biologics and Dynavax Technologies.
  Full (0)
  
  Emergency (2)
   Taiwan
   Paraguay
  
  Non-country entities
   Somaliland
  
  Travel-only
   Belize
   Indonesia
   Malaysia
   New Zealand
   Palau
   Thailand
   Turkey
  
  Corbevax 
  Corbevax is a protein subunit vaccine developed by Texas Children's Hospital at the Baylor College of Medicine in Houston, Texas, and licensed to Indian biopharmaceutical firm Biological E. Limited (BioE) for development and production.
  
  Full (0)
  
  Emergency (2)
   India
   Botswana
  
  Travel-only
   Malaysia
   New Zealand
   Turkey
  
  COVIran Barekat 
  
  COVIran Barekat, is an inactivated virus vaccine developed by Shifa Pharmed Industrial Co. in Iran.
  Full (0)
  
  Emergency (1)
   Iran
  
  Travel-only
   Malaysia
   New Zealand
   Hungary
  Turkey
  
  Chinese Academy of Medical Sciences 
  
  Chinese Academy of Medical Sciences COVID-19 vaccine, is an inactivated virus vaccine developed by Chinese Academy of Medical Sciences.
  Full (0)
  
  Emergency (1)
   China
  
  Travel-only
   Hong Kong
   New Zealand
   Turkey
  
  ZyCoV-D 
  ZyCoV-D, is a DNA plasmid based COVID-19 vaccine developed by the Indian pharmaceutical company Cadila Healthcare with support from the Biotechnology Industry Research Assistance Council.
  Full (0)
  
  Emergency (1)
   India
  
  Travel-only
   Malaysia
   New Zealand
   Turkey
  
  FAKHRAVAC 
  
  FAKHRAVAC (or MIVAC), is an inactivated virus vaccine developed in Iran by the Organization of Defensive Innovation and Research, an organization of Iran's Ministry of Defense.
  Full (0)
  
  Emergency (1)
   Iran
  
  Travel-only
   Hungary
   Malaysia
   New Zealand
   Turkey
  
  COVAX-19 
  
  COVAX-19, also known as SpikoGen, is a protein subunit vaccine jointly developed by Australian-based company Vaxine and Iran-based company CinnaGen.
  Full (0)
  
  Emergency (1)
   Iran
  
  Travel-only
   Hungary
   Malaysia
   New Zealand
   Turkey
  
  Razi Cov Pars 
  
  Razi Cov Pars is a protein subunit vaccine developed by Razi Vaccine and Serum Research Institute.
  Full (0)
  
  Emergency (1)
   Iran
  
  Travel-only
   Hungary
   Malaysia
   New Zealand
   Turkey
  
  Turkovac 
  
  Turkovac is an inactivated vaccine developed by Health Institutes of Turkey and Erciyes University.
  
  Full (0)
  
  Emergency (1)
   Turkey
  
  Travel-only
   Malaysia
   New Zealand
  
  Sinopharm CNBG 
  Sinopharm CNBG COVID-19 vaccine is a recombinant protein subunit vaccine developed by China National Biotec Group (CNBG), a subsidiary of Sinopharm.
  
  Full (0)
  
  Emergency (1)
   United Arab Emirates
  
  Travel-only
   Malaysia
   Turkey
  
  Soberana Plus 
  Soberana Plus is a single-dose of conjugate vaccine developed by the Finlay Institute in Cuba.
  
  Full (0)
  
  Emergency (1)
   Cuba
  
  Travel-only
   Guyana
   Malaysia
   New Zealand
   Turkey
  
  CoVLP 
  CoVLP is a Virus-Like Particle vaccine grown in an Australian weed, Nicotiana benthamiana. It is marketed under the name Covifenz.
  
  Full (1)
   Canada
  
  Emergency (0)
  
  Travel-only
   Malaysia
   New Zealand
   Turkey
  
  Noora 
  Noora is a protein-based vaccine developed by the Baqiyatallah University of Medical Sciences.
  
  Full (0)
  
  Emergency (1)
   Iran
  
  Travel-only
   Malaysia
   Turkey
  
  SKYCovione 
  
  SKYCovione is a protein subunit vaccine developed by SK Bioscience.
  
  Full (0)
  
  Emergency (1)
   South Korea
  
  Тэмдэглэл
  
  Зүүлтэ 
  
   
  Медицинскэ шэнжэлэлгэ